Illumina, Inc. (NASDAQ: ILMN) today announced a multi-year partnership with Agendia N.V., a world leader in precision oncology for breast cancer, to co-develop in vitro diagnostic (IVD) tests for oncology testing. The partnership is intended to…

Alkermes is committed to researching and developing potential new cancer treatment options that may help address unmet patient needs.

Making CES history, Abbott presented a keynote at the most influential tech event in the world, the first healthcare company ever to do so.

Bill Jarvis, our Senior Process Engineer, Sr. Associate, shares, "Those of us at CRB feel like we have grown up with the RNA industry; we’ve watched this technology space go from niche to one of the hottest areas of biopharma development."

Whenever you eat foods, you are getting a certain number of calories. But what else are you getting? Nutrition is more than calories alone and it takes well-balanced meals.

Quest sponsored the Modern Healthcare webinar, “Collaborating to address health inequities in underserved communities.”

COVID-19 inflicted tremendous suffering in 2021, taking almost 3.5 million lives this year, more than died from HIV/AIDS, tuberculosis and malaria combined last year.

Gilead’s Rohini Mehtani, Ph.D. reflects on the importance of ASH21.

According to the World Health Organization, one person around the world dies in a road collision every 24 seconds—a tragedy totaling 1.3 million people each year

Although the holidays typically are one of the most joyous times of the year, it also can be a time of great stress for some families.

Quest Diagnostics was honored to collaborate with Choose Health Life and the United Way of New York City on the Choose Healthy Life Black Clergy Conclave.

One year ago, FedEx Express, a subsidiary of FedEx Corp. and the world’s largest express transportation company, delivered the first shipments of the COVID-19 vaccines to dosing centers in the United States.

Svetlana Izambaeva was 22 years old when she learned she had contracted HIV from her boyfriend in 2002. The news shocked her.

Merck and Ridgeback Biotherapeutics announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for molnupiravir, an investigational oral antiviral (MK-4482, EIDD-2801).

When entrepreneur Ridhi Tariyal walked out of Boston’s Brigham & Women’s Hospital in the fall of 2013, she left feeling frustrated.

A child’s smile is one of their earliest expressions of joy and connection. Unfortunately for children born with congenital ear and facial deformities, they are not only deprived of a smile, but also a healthy life from the complications that follow.

The SABCS brings the scientific community and advocates together to focus on the biggest needs in breastcancer, including how the disease uniquely affects Black women.

RESOLVE, on behalf of a multi-sector consortium, announced today the launch of HealthGrid Sierra Leone, an initiative to provide sustainable electricity and other essential services to off-grid health facilities in Sierra Leone.

While coping with the effects of cancer during the holidays is difficult, we find hope in the research work being done at Alkermes to help expand the future of cancer treatment for patients and their families.

This week, we flew over 1 million doses of COVID-19 vaccines from Washington D.C. to Accra, Ghana in partnership with UNICEF’s humanitarian initiative, COVAX which aims to provide access to COVID-19 vaccines to every country around the world.

“My child has a reason to smile. We used cans before, but now we have a reason to smile.” This is one of many heartfelt testimonials for the Utulav toilet, created by Syna Consultancy in Kenya.

Merck and Ridgeback Biotherapeutics announced the New England Journal of Medicine has published findings from the Phase 3 MOVe-OUT trial evaluating molnupiravir, an investigational oral antiviral COVID-19 medicine.

At the beginning of the pandemic, many public health experts feared that India’s ultra-high-density cities, high income inequality and comparatively low healthcare spending would likely create the perfect storm.

Illumina, Inc. (NASDAQ:ILMN), announced that it is supporting a national precision medicine study in Norway to assess the efficacy of blood-based comprehensive genomic profiling (CGP) in cancer therapy selection testing.

With more than 130 employees at 200+ sites across the globe, Medtronic LABS is an independent, non-profit organization with multiple entities including an operating foundation, a social business, and in-country subsidiaries that creates technology-…